CVS Health ROE - Return on Equity 2010-2025 | CVS

CVS Health return on equity for the quarter ending March 31, 2025 was 6.97.

  • CVS Health average return on equity for 2024 was 8.05, a 2.31% decline from 2023.
  • CVS Health average return on equity for 2023 was 8.24, a 1.23% decline from 2022.
  • CVS Health average return on equity for 2022 was 8.14, a 22.77% increase from 2021.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

CVS Health ROE - Return on Equity 2010-2025 | CVS

  • CVS Health average return on equity for 2024 was 8.05, a 2.31% decline from 2023.
  • CVS Health average return on equity for 2023 was 8.24, a 1.23% decline from 2022.
  • CVS Health average return on equity for 2022 was 8.14, a 22.77% increase from 2021.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$146.6B
Elevance Health (ELV)$77B
Cencora (COR)$57.2B
DiDi Global (DIDIY)$24.2B
Natera (NTRA)$21.9B
Labcorp Holdings (LH)$20.9B
BioMerieux (BMXMF)$16.9B
EUROFINS SCIENT (ERFSF)$13.7B
CochLear (CHEOY)$12.8B
Solventum (SOLV)$12.8B
ICON (ICLR)$12.2B
Revvity (RVTY)$12B
Viatris (VTRS)$10.7B
Medpace Holdings (MEDP)$9.3B
Avantor (AVTR)$9.3B
Sonic Healthcare (SKHHY)$8.9B
HealthEquity (HQY)$8.2B
Charles River Laboratories (CRL)$7.8B
Caris Life Sciences,�Inc (CAI)$6.7B
Amplifon S.p.A (AMFPF)$5.4B
Bausch + Lomb (BLCO)$4.9B
BrightSpring Health Services (BTSG)$3.6B
Sotera Health (SHC)$3.3B
Surgery Partners (SGRY)$2.8B
Alignment Healthcare (ALHC)$2.6B
Organon (OGN)$2.6B
Concentras Parent (CON)$2.6B
GeneDx Holdings (WGS)$2.4B
Ardent Health (ARDT)$2B
Progyny (PGNY)$2B